Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Transplant for Ulcerative Colitis
NCT03948919Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2019
- Primary completion
- Nov 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in ulcerative colitis (UC) comparing FMT Treatment with Placebo (2 arms). Primary endpoint: Engraftment of donor microbiota at 12 weeks. Started Jul 2019; status: completed.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03948919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03948919.